<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03828487</url>
  </required_header>
  <id_info>
    <org_study_id>RAMA0004</org_study_id>
    <nct_id>NCT03828487</nct_id>
  </id_info>
  <brief_title>Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates</brief_title>
  <official_title>Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the performance of the O3 cerebral oximeter and sensor to
      a 510(k) cleared NIRS (Near-Infrared Spectroscopy) device on neonatal subjects based on data
      collected from the cutaneously placed forehead sensors. Due to the design of the systems, the
      devices will be used serially instead of concurrently. Because of this timing, changes in
      patient state may not be reflected in measurements collected by both devices.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty in implementing study protocol in the study population.
  </why_stopped>
  <start_date type="Actual">December 19, 2018</start_date>
  <completion_date type="Actual">June 14, 2019</completion_date>
  <primary_completion_date type="Actual">June 14, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rSO2 Bias</measure>
    <time_frame>Data collection period; alternating sensors every 5 minutes for up to 20 minutes.</time_frame>
    <description>rSO2 values collected from the control device (510(k) cleared regional oximetry sensor) and the investigational device (Masimo O3 neonatal sensors) will be used to compute determine the bias.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rSO2 Precision</measure>
    <time_frame>Data collection period; alternating sensors every 5 minutes for up to 20 minutes.</time_frame>
    <description>rSO2 values collected from the control device (510(k) cleared regional oximetry sensor) and the investigational device (Masimo O3 neonatal sensors) will be used to determine the precision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rSO2 RMS</measure>
    <time_frame>Data collection period; alternating sensors every 5 minutes for up to 20 minutes.</time_frame>
    <description>In order to obtain the RMS value, rSO2 values collected from the control device (510(k) cleared regional oximetry sensor) is subtracted from the rSO2 values collected from the investigational device (Masimo O3 neonatal sensors) for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the RMS Error value.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Regional Saturation of Oxygen (rSO2)</condition>
  <arm_group>
    <arm_group_label>Neonatal Test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive a Masimo O3 Neonatal sensors as well as a 510(k) cleared sensor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Masimo O3 Neonatal Sensors</intervention_name>
    <description>Regional Oximetry sensor for Neonates</description>
    <arm_group_label>Neonatal Test group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>510(k) cleared sensor</intervention_name>
    <description>Cleared Regional Oximetry sensor for Neonates</description>
    <arm_group_label>Neonatal Test group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Less than 10 kg

          -  Subjects less than or equal to 28 days old

        Exclusion Criteria:

          -  Underdeveloped skin at sites of sensor placement

          -  Jaundice or bilirubin levels out of normal range

          -  Subject has skin abnormalities affecting the sensor placement area such as psoriasis,
             eczema, angioma, scar tissue, burn, fungal infection, or substantial skin breakdown
             that would prevent monitoring of oxygenation levels during the study

          -  Subject deemed not eligible based on Principal Investigator's judgment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 10, 2019</study_first_submitted>
  <study_first_submitted_qc>January 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <pending_results>
    <submitted>May 6, 2020</submitted>
    <returned>May 21, 2020</returned>
    <submitted>June 16, 2020</submitted>
    <returned>June 29, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

